ACUMEN PHARMACEUTICALS, INC. (ABOS)
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Innovative Industrial Properties Announces PharmaCann Resolution and Provides Portfolio Update
Dollar Tree, Inc. Reports Fourth Quarter and Full Year 2025 Results
“One Battle After Another” Wins USA TODAY’s Movie Meter Competition
PulteGroup Nominates Ben Schall for Election to Board of Directors
Forgent Reports Second Quarter 2026 Results, Accelerating Order Growth and Issues Fiscal 2026 Guidance
Nova Winter Freight Haul Underway
Riverstone Holdings Limited - Announcement
KE Holdings Inc. Announces a Final Cash Dividend of US$0.3 Billion in Aggregate